$2.8 Million Approved for GWS ResearchAugust 02, 2010
Air Force News
WASHINGTON -- Department of Veterans Affairs officials have approved $2.8 million to fund three new research projects that focus on testing or developing new treatments for illnesses affecting veterans who served in the Gulf War from 1990 to 1991.
The research incorporates recommendations of the department's Gulf War Veterans' Illnesses Task Force.
"Reaching out to Gulf War Veterans is essential to the transformation of VA," said John R. Gingrich, the Veterans Affairs chief of staff. "This research is a great opportunity to do something that will improve the care and services these veterans have earned."
About 697,000 men and women served in operations Desert Shield and Desert Storm from August 1990 to June 1991 during the Gulf War. In the years since they returned, nearly a quarter of these veterans have experienced chronic symptoms such as fatigue, weakness, gastrointestinal problems, cognitive dysfunction, sleep disturbances, persistent headaches, skin rashes, respiratory conditions and mood changes. The symptoms are known collectively as "Gulf War Veterans' illnesses."
A recent report by the Institute of Medicine's Committee on Gulf War and Health, "Health Effects of Serving in the Gulf War," noted that chronic multi-symptom illnesses affect an estimated 250,000 Gulf War Veterans. Given the findings, VA officials are embarking on a national Gulf War Veterans' illness research program to identify and adopt the most effective treatments for veterans.